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Abstract
Background: Useful probes of the intracellular environment that target a specific organelle in order to allow direct
observation of the changes in these regions is of high current interest. Macrocyclic ligands have already revealed themselves
as important selective hosts in some biological applications, forming stable and specific complexes. Therefore, in this paper,
several macrocyclic ligands are evaluated as potential molecular probes.
Methodology: Four polyammonium macrocycles and one macrotricyclic bearing pyridine and phenanthroline
chromophores have been synthesised and evaluated as molecular probes. The cytotoxicity of the compounds has been
analyzed using human breast cancer cells (MCF-7), non-cancerous human dermal fibroblasts (NHDF) and human adult
dermal skin fibroblasts from a breast cancer patient (P14). All the compounds showed low toxicity at concentrations ranging
from 10 nM to 10 mM, except for [32]phen2N4 which proved to be highly cytotoxic for MCF-7 cells. Flow cytometry studies
evidenced that the percentage of apoptotic and necrotic MCF-7 and NHDF cells induced by the compounds is considerably
low. Also, flow cytometry analysis showed that some compounds seem to modify the mitochondrial membrane potential
(MMP) of the cells. Fluorescence microscopy evidenced that compounds easily cross the plasma membrane (5 min) and
accumulated into the mitochondria, as confirmed by co-localization with MitoTracker Green
TM. The fluorescence images
also evidenced an intact mitochondria structure after 48 h. Moreover, reticular staining suggestive of endoplasmic reticulum
(ER) localization, in addition to the mitochondrial one, has been found by confocal microscopy.
Conclusion: Our study reveals that compounds Me2[28]py2N6, cryptphen, [16]phenN2, [30]phen2N6, have low toxicity and
localize in mitochondria and ER. The ability of these compounds for translocating the cellular membrane (5 min) without
special conditioning of the cells or derivatization of the probe, the time-dependent localization (48 h) and the cellular
viability provide a proof-of-concept towards their use as promising probes towards biomedical studies.
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Introduction
The development of new responsive fluorescent probes that
involve minimal perturbation of the biological system is essential for
understanding the structure and the function of the cellular
processes [1]. These systems must be adapted to the constraints
imposed by the complex intracellular environment [2]. Some key
issues must be addressed in devising a probe suitable to be used in
living cells. For instance, the probe should be able to cross the outer
lipid membrane at relatively fast rate and maintain the integrity and
performance at cellular level, should exhibit an intracellular
localization profile that is amenable for imaging microscopy
observation, and should target a specific organelle keeping the cell
viability, proliferation and membrane permeability, among others.
The majority of probes that have been developed over the last years
are based on emissive metal complexes [3], recombinant proteins
[4], semiconductor nanoparticles, [5] (often termed quantum dots)
and organic fluorophores with low molecular weight, such as,
rhodamine, fluorescein, cyanine dyes and dipyrroylmethane [6–9].
However, the application of these probes is limited due to several
properties,such as:lowwaterand mediumincubationsolubility,pH
range, optimal pKa value, toxicity and cell penetration [10].
The dynamic contacts between the subcellular organelles are a
common structural and functional feature affecting many cellular
processes [11]. For instance, several studies suggested that the
close contact between vesicular/tubular networks of mitochondria
and the endoplasmic reticulum (ER) are crucial for the synthesis
and intracellular transport of phospholipids, as well as, for
intracellular Ca
2+ homeostasis, controlling fundamental processes
like motility and contraction, secretion, cell growth, proliferation
and apoptosis [12]. It has been found that MAM (mitochondria
associated membranes) and peptidic tethers keep mitochondria
and ER in close contact. Immunofluorescence analysis has already
confirmed and explained this juxtaposition between ER-mito-
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immunofluorescence analysis, that this inter-organellar protein
linkage between ER and mitochondria can be weakened (or
strengthened) by rupture (or enforcement) of their networks [13–14].
Available fluorescent dyes known to target specific organelles,
such as, LysoTracker
TM, ER-Tracker
TM and MitoTracker
TM,
allow the monitorization specific functions of the corresponding
organelle and can be used in lower concentrations for any
experimental approach [15]. For instance, the chloromethyl
derivatives of the fluorescent cationic rosamine probes (Mito-
Tracker
TM), currently used as mitochondrial probes, are lipophilic
and cationic compounds that can accumulate electrophorethically
into mitochondria in response to changes of mitochondrial
membrane potential [16]. Basically, the reactive chloromethyl
groups can form covalent bonds with SH groups mitochondrial
proteins, avoiding their release even if mitochondria depolarize
[16].
Other types of molecules that have been observed to localize on
mitochondria are based on europium(III) and terbium(III)
complexes of heptadentate ligands bearing azaxanthone or
azathiaxanthone [17–19]. Co-staining experiments with these
complexes revealed that merging from mitochondria to the
lysosomes occurred only after considerably long incubation times
(.4 h incubation) [20].
Macrocyclic ligands, such as cyclodextrins [21], calixarenes
[22], crown ethers [22] and polyheterocycles with oxazole rings
[23], have already revealed themselves as important selective hosts
in some biological applications: drug solubilizers, drug stabilizers
and anticancer agents [24–26].
In this paper, the potential of five pyridine or phenanthroline-
containing macrocycles (see Figure 1) as mitochondria and ER
fluorescent probes is thoroughly explored. The cellular toxicity of
the compounds is evaluated on breast cancer cells (MCF-7),
non-cancerous human dermal fibroblasts (NHDF) and human
adult dermal skin fibroblasts from a breast cancer patient
(designated as P14) by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide)] assay. The apoptosis induced on
MCF-7 and NHDF cells and the MMP are evaluated by flow
cytometry. The compounds ability to penetrate the intracellular
medium and their localization is accomplished by fluorescence
microscopy. Confocal images provide clear evidence of mitochon-
drial staining and additional ER localization.
Results
Ligand synthesis
Compounds Me2[28]py2N6, [32]phen2N4 and [30]phen2N6
have been prepared as recently described in [27,28]. Compound
[16]phenN2 is a versatile precursor for the assembly of macro-
polycyclic cryptphen, since it contains two secondary amine groups
that can be connected by 2:2 cyclizations with 1,0-phenanthroline
moieties.Thesynthesis of[16]phenN2 and cryptphenis described in
Experimental section, as well as, the compounds characterization.
Toxicology assays on MCF-7, NHDF and P14 cells
One of the key issues to consider a probe suitable for living cells
use is its cellular toxicity. In this context, the cytotoxicity of the five
synthesised macrocyclic compounds is assessed by a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as-
say. The cytotoxicity of the starting material 1,10-phenanthroline-
2,9-dicarbaldehyde is measured by MTT assay for comparison. In
this quantitative colorimetric assay, the amount of MTT reduced
by cells to its formazan derivative is quantified spectroscopically at
570 nm and is considered equivalent to the number of viable cells
[29]. The cytotoxicity of the referred compounds is evaluated
using human breast cancer cells (MCF-7), non-cancerous human
Figure 1. Chemical structures of pyridine or phenanthroline-containing macrocycles.
doi:10.1371/journal.pone.0027078.g001
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fibroblasts (designated P14) obtained from the breast biopsy
specimen of a woman diagnosed with breast cancer. All cells have
been exposed to the six different compounds in five concentrations
ranging from 10 nM to 100 mM during a period of exposition of
48 h. The results are presented in Figure 2.
Afterward, it has been analyzed if the compounds induced
apoptotic or necrotic responses using flow cytometry. For this
purpose, the fluorescein isothiocyanate (FITC)-conjugated annexin
V - PI (propidium iodide) flow cytometry assay is employed,
allowing the identification of apoptosis and necrosis [30]. Thus,
MCF-7 and NHDF cells are treated with two concentrations
(10 nM and 10 mM) of each compound for 48 h. These
concentrations are above IC50 values, except for [32]phen2N4 on
MCF-7 cells.
A dot-plot of Annexin V- FITC vs. PI showed four separate cell
populations: viable cells (Annexin-V
2/PI
2), early apoptotic cells
(Annexin-V
+/PI
2), late apoptotic cells (Annexin-V
+/PI
+) and
necrotic cells (Annexin-V
2/PI
+).
Those percentages of NHDF and MCF-7cells that are in early
apoptotis, late apoptotis and necrosis, comparing to the control,
are presented in Figures 3 and 4, respectively.
Flow cytometry plots indicate that the percentage of early
apoptotic and necrotic cells resulting from compounds treatment
with NHDF is considerably low (,5%) at both concentrations
(Figure 3). However, the percentage of late apoptotic NHDF cells
was about 20% at the concentration of 10 mM for 1,10phen and
[16]phenN2.
For MCF-7 cells the degree of early and late apoptosis induced
by the majority of the compounds is less than 20% for both
concentrations (10 nM and 10 mM). It seems that MCF-7 cells are
more sensitive than NHDF cells (Figure 4).
Microscopy studies
The timescale of trafficking of these compounds and their sub-
cellular localization have been subsequently examined in MCF-7,
NHDF and P14 cells using fluorescence microscopy. The cells are
mounting on 0.1 mm thick glass cover slips by withdrawal of the
respectively growth medium.
The incubation times to test the ability compounds to penetrate
into cells varied from 5 min to 48 h, and concentrations onto the
cells were 10 nM and 100 mM by dissolving in appropriate
medium. As a control measure, untreated cells were also examined
and showed no fluorescence. By analyzing each image recorded,
all the compounds in all cells rapidly crossed the cell membrane
(5 min) and induced a slight stain in the first minutes of
incubation, depending on the type of cells. However, for
incubation times longer than 30 min, it seems that this difference
in the stained disappeared, thus appearing that the compounds
were localized into an organelle of the cytoplasm. The cells images
at 5 min and 48 h of compounds [30]phen2N6 and cryptphen in
MCF-7, NHDF and P14 cells are presented in Figures 5 and 6.
InFiguresS1,S2,S3,S4andS5thefluorescenceimagesofMCF-
7, NHDF and P14 treated with cryptphen 10 nM after 1 h, 3 h,
6 h, 24 h and 36 h of incubation are presented. Based on these
images, it has also been detected an intense fluorescence around the
nuclear membrane, consistent with localization in mitochondria.
Generally, no relevant signs of cytotoxicity have been observed
when working at concentrations 10 nM and 100 mM over 48 h for
all macrocycles, even in the presence of compound [32]phen2N4,
which is clearly favorable for their use as cellular probes.
Besides, the subcellular localization of the compounds has been
confirmed by co-staining with MitoTracker
TM (25 nM, 45 min of
incubation) and ER-Tracker
TM (100 nM, 30 min of incubation)
probes in MCF-7, NHDF and P14 cells, with compound
concentrations of 10 nM and 100 nM and for incubation times
of 1 h. Also, co-staining with probe Hochest 33342 has shown that
the compounds do not localize to the nucleus. Confocal
fluorescence images showed that the luminescence pattern is
consistent with a mitochondrial distribution, with the merged
images of red and green channels showing good correspondence.
In addition, partial reticular staining has been observed on
confocal images, which is suggestive of endoplasmic reticulum
localization. Selected images of Me2[28]py2N6 co-localization in
NHDF cells with Mitotracker
TM and ER-Tracker
TM are present-
ed in Figures 7 and 8, respectively.
Discussion
The data presented in Figure 2 showed that, in spite of the
general low cytotoxicity of the macrocycles, some interesting
differences in their effects are noticeable on these three different
human cells. Hence, compounds Me2[28]py2N6, cryptphen,
[16]phenN2, [30]phen2N6, and 1,10-phen are not significantly
cytotoxic to MCF-7 cells, according to the IC50 values that are
higher than 100 mM. In contrast, the IC50 value for [32]phen2N4
is in low micromolar range (,0.01 mM), suggesting that at this
concentration this compound shows a remarkable cytotoxicity.
Otherwise, the data of [32]phen2N4 to fibroblast cells (NHDF and
P14) suggested less cell toxicity. The IC50s are 78.9262.82 and
Figure 2. Relative cell viability of MCF-7, NHDF and P14 cells (0.5610
4 cells/well) incubated with Me2[28]py2N6, [32]phen2N4,
cryptphen, [16]phenN2, [30]phen2N6 and 1,10-phen, in concentrations ranging from 0–100 mM and using the MTT assay at 48 h,
determining formazan absorbance at 570 nm. Mean values 6 SEM are obtained from three experimental determinations. Data are expressed
as a percentage of cell viability in comparison with the control; the bars represent the mean and the lines represent the SEM associated. *P,0.05
versus the control (one-way ANOVA with Dunnet’s post-hoc test).
doi:10.1371/journal.pone.0027078.g002
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PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27078Figure 3. Relative percentages of viable cells (LL), early apoptotic cells (LR), necrotic cells (UL) and late apoptotic cells (UR) induced
by Me2[28]py2N6, [32]phen2N4, cryptphen, [16]phenN2, [30]phen2N6 and 1,10-phen in NHDF cells. The cells have been treated with
concentrations 10 nM and 10 mM of each compound for 48 h and comparing with the control.
doi:10.1371/journal.pone.0027078.g003
Figure 4. Relative percentages of viable cells (LL), early apoptotic cells (LR), necrotic cells (UL) and late apoptotic cells (UR) induced
by Me2[28]py2N6, [32]phen2N4, cryptphen, [16]phenN2, [30]phen2N6 and 1,10-phen in MCF-7 cells. The cells have been treated with
concentrations 10 nM and 10 mM of each compound for 48 h and comparing with the control.
doi:10.1371/journal.pone.0027078.g004
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toxic effect in cancer cells versus cell viability in normal cells
encouraged us to further explore the interest of this compound as a
potential future anticancer agent.
For the remaining compounds the IC50s obtained are in high
micromolar range (.100 mM), except for Me2[28]py2N6 in P14
that has a IC50 of 36.7964.68 mM, showing that Me2[28]py2N6 is
more toxic to P14 than to NHDF cells (IC50 of 69.6763.02 mM).
Also, at 0.1 mM for cryptphen and [16]phenN2 in NHDF cells,
approximately 50% reduction in cell viability has been observed
while in P14 it was not observed. However, the increase of the
concentrations of these compounds to 1 mM, 10 mM and 100 mM
does not lead to an increase in the NHDF and P14 cells death.
Hence, the cytotoxicity data obtained over 48 h cell incubation
period at range of concentrations of 0.1 and 10 mM motivated us to
further explore the potential utility of the fluorescent macrocycles
cryptphen, [16]phenN2 and [30]phen2N6 as molecular probes.
Based on Annexin V- FITC vs. PI flow cytometry assay no
remarkable effects of these compounds in the induction of
apoptosis and necrosis has been observed in comparison with
control cells. It has been found that MCF-7, as cancer cells, seems
to be more sensitive at the concentrations tested than NHDF.
Indeed, the higher cell viability value of MCF-7 incubated with
10 mMo fM e 2[28]py2N6, determined by MTT assay, can be an
artifact since no relevant apoptosis has been found.
The sub-cellular localization of compounds was confirmed by
the use of commercially available cellular stains for mitochondria,
nucleus and endoplasmic reticulum. All the compounds studied do
not localize to the nucleus. The inspection of the fluorescence
microscopy images showed ER–mitochondria localization at all
incubation times, from 5 min to 48 h. No signs of rupture of
plasma membrane have been observed and the cellular architec-
ture and integrity of the mitochondria was preserved in the
presence of the compounds. The images showed the typical
pattern of mitochondrial organization present in MCF-7 and
NHDF obtained in previous studies [31–33]. Considering the
nature of the chromophore structure (phenanthroline and
pyridine) on the compounds localization, no marked changes
have been observed on their mitochondrial-ER distribution in the
three different human cells.
A possible explanation about their preferential accumulation in
mitochondria is that at physiological pH the compounds carried
out a delocalized positive charge, allowing permeating plasma
membrane, as well as, the mitochondrial membranes [34].
In order to study the effects of the compounds in mitochondrial
membrane potential (MMP) of MCF-7 and NHDF cells, flow
cytometry assay was employed to monitor any fluorescence
changes in MitoTracker Green
TM and red fluorescence of
chloromethyl-X-rosamine (CMXRos), treatment with the uncou-
pler 2,4-dinitrophenol (2,4-DNP) to collapse the MMP. While
MitoTracker Green
TM staining was relatively unaffected by
changes in MMP, the CMXRos staining of mitochondria is
sensitive to MMP [30]. Also, laser scanning confocal microscopy
was employed to analyze changes in mitochondrial localization by
Figure 5. Fluorescence microscopy images of [30]phen2N6
(10 nM) in (a) NHDF, 5 min, (b) NHDF, 48 h, (c) MCF-7, 5 min,
(d) MCF-7, 48 h, (e) P14, 5 min and (f) P14, 48 h; (1610
4 cells/
dish).
doi:10.1371/journal.pone.0027078.g005
Figure 6. Fluorescence microscopy images of cryptphen
(10 nM) in (a) NHDF, 5 min, (b) NHDF, 48 h, (c) MCF-7, 5 min,
(d) MCF-7, 48 h, (e) P14, 5 min and (f) P14, 48 h; (1610
4 cells/
dish).
doi:10.1371/journal.pone.0027078.g006
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Tracker Green
TM and compounds.
Theflow cytometryassayforMCF-7showedthatthe compounds
exhibit a decrease of red fluorescence comparing with the posi-
tive control (2,4-DNP), in particular for Me2[28]py2N6 and
[16]phenN2. These changes in the MMP give rise to FL4/FL1
intensities lower than positive control. Thisseems to indicate that all
the compounds disrupt the mitochondrial membrane potential of
MCF-7 cells. Nevertheless, for NHDF cells only compounds
[16]phenN2 and cryptphen seem to modify the MMP by exhibiting
a decrease of FL4/FL1 ratio comparing to the positive control. For
the remaining compounds no changes in the MMP was detected.
On the other hand, these changes do not seem to have a
remarkable effect on cell death, according to the results of Annexin
V- FITC presented in Figures 3 and 4.
The fluorescence images of the cells treated with 300 mMo f
uncoupler 2,4-DNP and stained with MitoTracker Green
TM and
compounds do not show significant differences inthe co-localization
in presence of 2,4-DNP. These compounds appear to localize
mitochondria besides disrupting its membrane potential, as
indicated by flow cytometry assay with CMXRos. The single laser
scanning confocal microscopy images of MCF-7 cells stained with
[30]phen2N6 and MitoTracker Green
TM and treated with 2,4-DNP
are presented in Figure S6. The untreated control cells are
presented in Figure S7, for comparison.
Relatively to the additional reticular staining localization, this
could be explained by spatial and functional organized network
mediated by mitochondrial proteins and mitochondria-associated
membranes that interconnect ER–mitochondria [14]. The
molecular mechanisms that controlled this interaction require
further investigation, which could be the subject of a future work.
In summary, our results clearly demonstrated that compounds
Me2[28]py2N6, cryptphen, [16]phenN2, and [30]phen2N6, are
able to be used as sub-cellular probes, having the ability for
translocating the cellular membrane without a special conditioning
of the cells, being also non-toxic at the concentrations used on the
three human cells tested (MCF-7, NHDF and P14). In every case,
all the compounds exhibited identical sub-cellular localization
patterns on mitochondria and endoplasmic reticulum in less than
1 h. This result also indicates that the nature of the chromophore
(phenanthroline and pyridine) does not affect the cellular
distribution. The fact that the compounds localize in both
mitochondria and endoplasmic reticulum also makes them ideal
candidates for their use as specific cellular probes, due to the
intimate liaison of the endoplasmic reticulum–mitochondria.
However, the compounds cell uptake mechanism requires future
investigation. The timescale of trafficking of these compounds
(5 min), the time-dependent localization (48 h) and the cellular
viability makes them promising molecular probes.
Materials and Methods
Reagents and solvents were of the purest grade available, and
were generally used without further treatment. 1,6-Hexanedia-
mine, diethylenetriamine, N,N-bis-(3-aminopropyl)-methylamine
and sodium borohydride were purchased from Aldrich. 1,10-
phenanthroline-2,9 dicarboxaldehyde and 2,9-bis(bromomethyl)-
1,10-phenanthroline were prepared as previously described in
Figure 7. Distribution and co-localization of Me2[28]py2N6 (100 nM, incubation time 1 h) with MitoTracker Green
TM (25 nM,
incubation time 45 min) in NHDF cells (1610
4 cells/dish) collected with a confocal laser scanning microscope; fluorescence images
of MitoTracker Green
TM (a) and Me2[28]py2N6 (b); or differential interference contrast (c) and merged images of red and green
channels (d); scale bar 10 microns.
doi:10.1371/journal.pone.0027078.g007
Figure 8. Distribution and co-localization of Me2[28]py2N6 (100 nM, incubation time 1 h) with ER-Tracker
TM Green (100 nM,
incubation time 30 min) in NHDF cells (1610
4 cells/dish) collected with a confocal laser scanning microscope; fluorescence images
of ER-Tracker
TM Green (a) and Me2[28]py2N6 (b); or differential interference contrast (c) and merged images of red and green
channels (d); scale bar 10 microns.
doi:10.1371/journal.pone.0027078.g008
Mitochondria-ER Targeting by Macrocyclic Compounds
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27078[35]. The synthesis of the compounds Me2[28]py2N6, [32]phen2N4
and [30]phen2N6 was also described previously [27,28].
Elemental analyses and electron spray ionization (ESI) mass
spectra were performed by the microanalysis service on a Fisons
EA-1108 microanalyzer and on a Bruker Daltonics Apex-Qe
instrument, respectively.
NMR spectra were recorded on a Bruker Avance II 400
operating at 400.13 MHz for protons and 100.62 MHz for carbons
and/or a Bruker Avance III 600 spectrometer operating at
600.13 MHz for protons and 150.96 MHz for carbons, equipped
with pulse gradient units. The reference used for the
1H NMR
spectra in D2O and MeOD-d4 was 3-(trimethylsilyl)propanoic acid-
d4 sodium salt. For
13C NMR spectra, dioxane was used as internal
reference.
All spectra were acquired at temperature of 298 K and using
the standard Bruker software.
Me2[28]py2N6
Yield 85%. m.p. 206–207uC.
1H NMR (600 MHz, D2O): d
(ppm) 2.04 (8 H, qt, NCH2CH2CH2N), 2.58 (6 H, s, NCH3), 3.08
(16 H, m, NCH2CH2CH2N), 4.28 (8 H, s, pyCH2N), 7.45 (4 H, d,
py)and 7.98 (2H, t,py).
13C NMR(600 MHz, D2O): d (ppm) 21.52
(NCH2CH2CH2N), 40.79 (NCH2CH2CH2N), 40.09 (NCH3), 50.54
(NCH2CH2CH2N), 52.89 (pyCH2N), 123.76 (py), 139.92 (py) and
150.08 (py). ESI-MS: m/z: 497.52 [L+H]
+. Anal. calc. for
C28H54Cl6N8O3: % C 40.04, H 7.92, N 14.65; found: % C
40.22, H 7.86, N 14.60.
[32]phen2N4
Yield 70%. m.p. 204–205uC.
1H NMR (600 MHz, D2O): d
(ppm)1.45(m,8H,NCH2CH2CH2),1.81 (m,8H,NCH2CH2CH2),
3.20 (m, 8H, NCH2CH2CH2), 4.71 (s, 8H, phenCH2N), 7.81 (d,
4H, phen), 8.01 (s, 4H, phen) and 8.55 (d, 4H, phen);
13C NMR
(600 MHz, D2O): d (ppm) 25.59 (NCH2CH2CH2), 27.08
(NCH2CH2CH2), 48.89 (NCH2CH2CH2), 50.65 (phenCH2N),
123.97, 128.21, 130.55, 141.25,145.22 and 153.13 (phen). ESI-
MS: m/z: 641.41 [L+H]
+. Anal. calc. for C40H65Cl5N8O6: C 51.59,
H 7.04, N 12.23; found: C 51.32, H 7.17, N 12.28.
[30]phen2N6
Yield 40%. m.p. 226–227uC.
1H NMR (600 MHz, D2O): d
(ppm) 3.51 (t, 8H, NCH2CH2N), 3.62 (t, 8H, NCH2CH2N), 4.54
(s, 8H, phenCH2N), 7.63 (d, 4H, phen), 7.88 (s, 4H, phen), 8.35 (d,
4H, phen);
13C NMR (600 MHz, D2O): d (ppm) 45.92
(NCH2CH2N), 49.52 (NCH2CH2N), 56.57 (phenCH2N), 125.52,
129.78, 131.35, 142.07, 146.02, 153.45 (phen). ESI-MS: m/z:
615.37 [L+H]
+. Anal. calc. for C36H54Cl8N10O2: % C 45.88, H
5.77, N 14.86; found: % C 45.75, H 6.09, N 14.63.
[16]phenN2
1,10-phenanthroline-2,9-dicarboxaldehyde (0.22 g, 0.93 mmol)
was previously dissolved in 100 mL of warm methanol and then
cooled to room temperature. This solution was dropped into
250 mL methanol solution containing 1,6-hexanediamine (0.12 g,
1.03 mmol) during 6 h at room temperature. The resulting
mixture was stirred for one night. The white solid formed was
filtered off and dissolved in ethanol (30 mL). Sodium borohydride
(0.09 g, 2.3 mmol) was then added in small portions to the cooled
mixture (in ice bath) and left it under stirring for 12 h at room
temperature. The solvent was removed under reduced pressure
and the resulted residue was treated with water and repeatedly
extracted with chloroform (4630 mL). After extraction, the
organic phases were combined and completely evaporated under
vacuum and then dissolved in ethanol (20 mL). The pure
compound was precipitated from concentrate hydrochloric acid
solution as a white powder easy to filter upon 12 h at 4uC.
Yield 92%. m.p. 210–211uC.
1H NMR (600 MHz, D2O): d
(ppm)1.44 (m,4H,NCH2CH2CH2), 1.80 (m,4H,NCH2CH2CH2),
3.22 (m, 4H,NCH2CH2CH2), 4.01(s,4H,phenCH2N), 7.76 (d, 2H,
phen), 7.97 (s, 2H, phen) and 8.50 (d, 2H, phen);
13CN M R
(600 MHz, D2O): d (ppm) 24.32 (NCH2CH2CH2), 32.90
(NCH2CH2CH2), 49.90 (NCH2CH2CH2), 55.50 (phenCH2N),
122.05, 126.82, 128.11, 135.60, 144.32 and 159.80 (phen). ESI-
MS: m/z: 321.21 [L+H]
+. Anal. calc. for C20H31Cl3N4O2:%C
51.57, H 6.71, N 12.03; found: % C 52.05, H 7.09, N 12.03.
cryptphen
A solution of [16]phenN2 (0.33 g, 0.83 mmol) in dry acetonitrile
(30 mL) was added, over a period of 3 h to a refluxing and
vigorously stirred suspension of 2,9-bis(bromomethyl)-1,10-phenan-
throline (0.30 g, 0.83 mmol) and Na2CO3 (0.87 g, 8 mmol) in dry
acetonitrile (40 mL). After the addition was completed the solution
was refluxed for additional 24 h. The resulting suspension was
filtered out and the solution was vacuum evaporated to give a oil.
The product was chromatographed on neutral alumina with
chloroform. The eluted fractions were collected and vacuum
evaporated and then dissolved in ethanol (20 mL). The pure
compound was precipitated from concentrate hydrobromic acid
solution as a white powder.
Yield 31%. m.p. 220–221uC.
1H NMR (600 MHz, MeOD-d4): d
(ppm)1.54 (m,8H,NCH2CH2CH2), 1.90 (m,8H,NCH2CH2CH2),
3.33 (m, 8H,NCH2CH2CH2), 4.75(s,8H,phenCH2N), 7.86 (d, 8H,
phen), 8.04 (s, 8H, phen) and 8.59 (d, 8H, phen);
13CN M R
(600 MHz, MeOD-d4): d (ppm) 24.44 (NCH2CH2CH2), 25.67
(NCH2CH2CH2), 58.53 (NCH2CH2CH2), 57.44 (NCH2CH2CH2),
60.52 (phenCH2N), 59.90 (phenCH2N), 138.76, 139.63, 142.95,
149.48, 150.27 and 152.06 (phen). ESI-MS: m/z: 1049.54 [L+H]
+.
Anal. calc. for C68H74Br8N12O:% C 47.63, H 4.35, N 9.80; found:
% C 47.97, H 4.39, N 9.96.
In vitro studies using MCF-7, NHDF and P14 cells
The cells used in this study were human breast cancer (MCF-7),
normal human dermal fibroblasts (NHDF) (both acquired to ATCC
– American Type Culture Collection) and human adult dermal skin
fibroblasts, designated P14, established from the breast biopsy
specimen of a consenting post-menopausal woman diagnosed with
breast cancer. We have obtained the ethics approval for our study
from the ethics committee (Comissa ˜o de E ´tica, in Portuguese) at the
Hospital Center of Cova da Beira (Centro Hospitalar da Cova da
Beira, in Portuguese) in Covilha ˜, Portugal, regarding the full usage
of Human Brest Cancer (Cancro da Mama, in Portuguese) Cells.
The consent was in written form.
Unless otherwise stated, chemicals (analytical grade), assay
reagents, culture media and supplements are all from Sigma-
Aldrich. Experiments were performed in 48-well tissue culture
plates and thick glass cover slips. The studied compounds were
dissolved in DMSO (1,10-phenanthroline-2,9 dicarboxaldehyde),
phosphate buffer (Me2[28]py2N6), DMSO/methanol 2:1
([32]phen2N4 and [16]phenN2) and 1:2 (cryptphen) and phosphate
buffer/methanol 1:2 ([30]phen2N6). The final solventconcentration
in the wells was #1%. This concentration of the solvents has no
effect on cell viability (data not shown).
Culture of cells
Cells were routinely maintained at 37uC in a humidified
atmosphere containing 5% CO2. Human dermal fibroblasts were
cultured in RPMI medium supplemented with 10% fetal bovine
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pyruvate (0.001 M) and 1% antibiotic/antimycotic (10,000 units/
mL penicillin, 10 mg/mL streptomycin and 25 mg/mL ampho-
tericin B). Dubelco’s Modified Eagle’s Medium high glucose
supplemented with 10% fetal bovine serum and 1% antibiotic/
antimycotic was used to culture MCF-7 cells. All the cells were
used between passages 3 to 10 in the experiments.
Analysis of cell viability (Cytotoxicity assay - MTT test)
Cell viability was studied quantifying the extent of the reduction
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) according to a previously described procedure [36].
Briefly, cells were seeded in 48-well plates (0.5610
4 cells/well) in
the culture medium containing FBS and after 48 h they were
treated with five concentrations (10 nM and 100 nM, 1 mM,
10 mM and 100 mM) of the different compounds for 48 h, with
untreated cells serving as control. At the end of incubation the
media in wells were removed and replaced with fresh media and
MTT solution and incubated at 37uC for 4 h. Thereafter, media-
containing MTT were removed and formazan crystals were
dissolved and absorbance was recorded in Biorad 550 microplate
reader at 570 nm. The extent of cell death was expressed as the
percentage of cell viability in comparison with control cells.
Fluorescence Microscopy
After growth in the glass bottom culture dishes coated with
collagen (1610
4 cells/dish), the cells were incubated in the dark at
37uC with 10 nM of all the compounds and analyzed from 5 min
to 48 h.
Prior to visualization, the excess probe was washed off by rinsing
in PBS four times. After mounting these samples, the compounds
were localized using a Zeiss AX10 microscope and the Axio Vision
Real 4.6 software.
In the co-localization experiment, cells were incubated in the dark
at 37uC with 100 nM of all the compounds for 1 h. The medium
was removed and the cells were then treated for 1 h with 25 nM
MitoTracker Green
TM, a potential-sensitive dye that accumulates in
mitochondria or with ER-Tracker
TM Green, a highly selective dye
for the endoplasmic reticulum. Prior to visualization, excess probe
was washed off by rinsing in PBS four times.
Confocal fluorescence imaging: the cells were observed with a
confocal laser scanning microscope (Carl Zeiss, LSM510 Meta)
with 405- and 488-nm laser excitation for the 4,6-diamidino-2-
phenylindole (DAPI) and fluorescein isothiocyanate (FITC)
channels, respectively. An appropriate emission band was selected
for the two fluorescent channels. A 636 ApoChromat,1.4-NA
objective (Carl Zeiss) was used to ensure high-resolution images.
DIC images were collected simultaneously with transmitted light
by excitation at 633 nm. Sequential rather than simultaneous
acquisition was used to avoid bleed-through between the two
fluorescent channels. Images were processed with LSM Image
Browser (Zeiss), ImageJ and Adobe Photoshop.
Flow Cytometry
To detect apoptosis, cells were stained with propidium iodide (PI)
and fluorescein isothiocyanate (FITC)-conjugated annexin V using
an Annexin V-FITC Apoptosis Detection Kit (BD Pharmin-
genTM). Briefly, cells were seeded in 75 cm
3 flasks in the culture
medium containing FBS and after reaching approximated 90%
confluence they were treated with two concentrations (10 nM and
10 mM) of each compound for 48 h, with untreated cells serving as
control. At the end of incubation, cells were harvested by trypsin-
EDTA treatment, washed twice with cold PBS and resuspended
with 16binding buffer (1 mL). Then, 100 ml of the cell suspension
was transferred to a culture tube and annexin V-FITC (5 ml) and PI
(10 ml) were added followed by incubation at room temperature in
the dark for 15 min. After the addition of 400 ml of 16 binding
buffer, stained cells were subjected to fluorescence-activated cell
sorter (FACS) analysis using a FACSCalibur flow cytometer. The
FITC fluorescence was measured between 515 and 545 nm and the
PI fluorescence between 564 and 606 nm. Data analysis was
performed using CellQuest
TM Pro Software.
The assessment of mitochondrial membrane potential was
determined as described previously [30]. Briefly, the cells were
incubated with 200 nM of MitoTracker Green
TM and 200 nM of
Mitotracker Red (CMXRos) for 30 min prior to harvesting. The
2,4-dinitrophenol (DNP) was used as a mitochondrial uncoupler
(300 mM, 2 h). The cells were treated with compounds concen-
tration 10 mM for 48 h. The relative mitochondrial membrane
potential was analyzed by flow cytometry by measuring the mean
intensity of FL1 (green) and FL4 (red) channels. The FL4/FL1
ratio intensities of compounds treated and positive control (DNP)
were compared and indicated if the compounds change the
mitochondrial membrane potential of the cells.
Statistics
All experiments were performed in triplicate. The IC50 values
were calculated from the obtained dose-response curve by sigmoid
fitting. Graphical results of citotoxicity were expressed as the
average values 6 SEM (standard error of mean). Comparison
among multiple groups was analyzed by using a one-way ANOVA
followed by Dunnet’s post hoc tests to determine significant
differences among the means. Difference between groups was
considered statistically significant at P,0.05.
Supporting Information
Figure S1 Fluorescence microscopy images of cryptphen in (a)
NHDF, (b) MCF-7 and (c) P14; cells incubation with 10 nM of
cryptphen during 1 h.
(TIF)
Figure S2 Fluorescence microscopy images of cryptphen in (a)
NHDF, (b) MCF-7 and (c) P14; cells incubation with 10 nM of
cryptphen during 3 h.
(TIF)
Figure S3 Fluorescence microscopy images of cryptphen in (a)
NHDF, (b) MCF-7 and (c) P14; cells incubation with 10 nM of
cryptphen during 6 h.
(TIF)
Figure S4 Fluorescence microscopy images of cryptphen in (a)
NHDF, (b) MCF-7 and (c) P14; cells incubation with 10 nM of
cryptphen during 24 h.
(TIF)
Figure S5 Fluorescence microscopy images of cryptphen in (a)
NHDF, (b) MCF-7 and (c) P14; cells incubation with 10 nM of
cryptphen during 36 h.
(TIF)
Figure S6 Single laser scanning confocal microscopy images of
MCF-7 cells (1610
4 cells/dish) treated with 2,4-DNP (300 mM,
2 h) and stained with [30]phen2N6 (100 nM, 1 h) and Mito-
Tracker Green
TM (25 nM, incubation time 30 min); (a) fluores-
cence images of MitoTracker Green
TM, (b) [30]phen2N6, (c)
differential interference contrast (d) and merged images of red and
green channels; scale bar 10 microns.
(TIF)
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MCF-7 cells (1610
4 cells/dish) stained with [30]phen2N6 (100 nM,
1 h) and MitoTracker Green
TM (25 nM, incubation time 30 min)
without2,4-DNP;(a)fluorescenceimagesofMitoTrackerGreen
TM,
(b) [30]phen2N6, (c) differential interference contrast (d) and merged
images of red and green channels; scale bar 10 microns.
(TIF)
Acknowledgments
Carla Cruz thanks Prof. Vı ´tor Fe ´lix and Prof. Rita Delgado for previous
discussions about the macrocyclic compounds. The authors thank Eurico
Cabrita from New University of Lisboa for access to the NMR facilities.
The authors thank Dr Olga Lourenc ¸o, Dr Mafalda Fonseca and Filomena
Silva for flow cytometry experiments and Ana Cristina Ramalhinho for
providing P14 cells. Also, the authors thank the anonymous reviewers for
their valuable comments, which greatly helped them to clarify and improve
the contents of the paper.
Author Contributions
Discussion of the results, corrections of the manuscript: CC SS LB EC PA
JQ. Conceived and designed the experiments: CC SS LB EC. Performed
the experiments: CC SS LB EC. Analyzed the data: CC SS LB EC.
Contributed reagents/materials/analysis tools: CC SS LB EC PA JQ.
Wrote the paper: CC.
References
1. Diaz G, Diana A, Falchi AM, Gremo F, Pani A, et al. (2001) Intra- and
Intercellular Distribution of Mitochondrial Probes and Changes after Treatment
with MDR Modulators. IUBMB Life 51: 121–126.
2. Craig P, Montgomery BS, Murray EJN, Robert P, Parker D (2009) Cell-
Penetrating Metal Complex Optical Probes: Targeted and Responsive Systems
Based on Lanthanide Luminescence. Acc Chem Res 42: 925–937.
3. Gill MR, Garcia-Lara J, Foster SJ, Smythe C, Battaglia G, et al. (2009) A
ruthenium(II) polypyridyl complex for direct imaging of DNA structure in living
cells. Nature Chem 1: 662–667.
4. Festy F, Ameer-Beg SM, Ngab T, Suhling K (2007) Imaging proteins in vivo
using fluorescence lifetime microscopy. Mol BioSyst 3: 381–391.
5. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, et al. (2005) Quantum
Dots for Live Cells, in Vivo Imaging, and Diagnostics. Science 28: 538–544.
6. Lavis LD, Raines RT (2008) Bright Ideas for Chemical Biology. Chem Biol 3:
142–155.
7. Domaille DW, Que EL, Chang CJ (2008) Synthetic Fluorescent Sensors for
Studying the Cell Biology of Metals. Nat Chem Biol 4: 168–175.
8. New EJ, Parker D, Smith DG, Walton JW (2010) Development of responsive
lanthanide probes for cellular applications. Curr Opin Chem Biol 14: 238–246.
9. Weissleder R, Hildebrand SA (2007) Optimized pH-responsive cyanine
fluorochromes for detection of acidic environments. Chem Commun 26:
2747–2749.
10. Wolfbeis OS (2005) Materials for fluorescence-based optical chemical sensors.
J Mater Chem 15: 2657–2669.
11. Brito MO, Scorrano L (2008) Mitofusin 2 tethers endoplasmic reticulum to
mitochondria. Nature 456: 605–610.
12. Lebiedzinska M, Szabadkai G, Jones WEA, Duszynskia J, Wieckowski MR
(2009) Interactions between the endoplasmic reticulum, mitochondria, plasma
membrane and other subcellular organelles. Int J Biochem Cell B 41:
1805–1816.
13. English AR, Zurek N, Voeltz GK (2009) Peripheral ER structure and function.
Curr Opin Cell Biol 21: 596–602.
14. Giorgi C, Stefani DD, Bononi A, Rizzuto R, Pinton P (2009) Structural and
functional link between the mitochondrial network and the endoplasmic
reticulum. Int J Biochem Cell B 41: 1817–1827.
15. Perry SW, Norman JP, Barbieri J, Brown EB, Gelbard HA (2011) Mitochondrial
membrane potential probes and the proton gradient: a practical usage guide.
Biotechniques 50: 98–115.
16. Scorrano L, Petronilli V, Colonna R, Di Lisa F, Bernardi P (1999)
Chloromethyltetramethylrosamine (Mitotracker Orange
TM) Induces the Mito-
chondrial Permeability Transition and Inhibits Respiratory Complex I. J Biol
Chem 274: 24657–24663.
17. Kielar F, Congreve A, Law G-L, New EJ, Parker D, et al. (2008) Two-photon
microscopy study of the intracellular compartmentalisation of emissive terbium
complexes and their oligo-arginine and oligo-guanidinium conjugates. Chem
Commun 21: 2435–2437.
18. Murray BS, New EJ, Pal R, Parker D (2008) Critical evaluation of five emissive
europium(III) complexes as optical probes: correlation of cytotoxicity, anion and
protein affinity with complex structure, stability and intracellular localization
profile. Org Biomol Chem 6: 2085–2094.
19. Law G-L, Pal R, Palsson LO, Parker D, Wong K-L (2009) Responsive and
reactive terbium complexes with an azaxanthone sensitiser and one naphthyl
group: applications in ratiometric oxygen sensing in vitro and in regioselective
cell killing. Chem Commun 47: 7321–7323.
20. Manning HC, Smith SM, Haviland MS, Bai S, Cederquist MFK, et al. (2006) A
Peripheral Benzodiazepine Receptor Targeted Agent for In Vitro Imaging and
Screening. Bioconjug Chem 17: 735–740.
21. Uekama K, Hirayama F, Irie T (1998) Cyclodextrin Drug Carrier Systems.
Chem Rev 98: 2045–2076.
22. Gokel GW, Leevy WM, Weber ME (2004) Crown Ethers: Sensors for Ions and
Molecular Scaffolds for Materials and Biological Models. Chem Rev 104:
2723–2750.
23. Monchaud D, Granzhan A, Saettel N, Gue ´din A, Mergny J-L, et al. (2010) One
Ring to Bind Them All—Part I: The Efficiency of the Macrocyclic Scaffold for
G-Quadruplex DNA Recognition. J Nucleic Acids 2010: 1–19.
24. Hettiarachchi G, Nguyen D, Wu J, Lucas D, Ma D, et al. (2010) PLoS ONE 5:
e10514.
25. Murray CW, Rees DC (2009) The rise of fragment-based drug discovery. Nature
Chem 1: 187–192.
26. Georgiades SN, Karim NHA, Suntharalingam K, Vilar R (2010) Interaction of
Metal Complexes with G-Quadruplex DNA. Angew Chem Int Ed 49:
4020–4034.
27. Cruz C, Carvalho S, Delgado R, Drew MGB, Fe ´lix V, et al. (2003) Metal
complexes of a dipyridine octaazamacrocycle: stability constants, structural and
modelling studies. Dalton Trans 16: 3172–3183.
28. Cruz C, Calisto V, Delgado R, Fe ´lix V (2009) Design of Protonated
Polyazamacrocycles Based on Phenanthroline Motifs for Selective Uptake of
Aromatic Carboxylate Anions and Herbicides. Chem Eur J 15: 3277–3289.
29. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival:
Application to proliferation and cytotoxicity assays. J Immunol Methods 65:
55–63.
30. New EJ, Congreve A, Parker D (2010) Definition of the uptake mechanism and
sub-cellular localization profile of emissive lanthanide complexes as cellular
optical probes. Chem Sci 1: 111–118.
31. Chen JQ, Delannoy M, Cooke C, Yager JD (2004) Mitochondrial localization of
ERa and ERb in human MCF7 cells. Am J Physiol Endocrinol Metab 286:
E1011–E1022.
32. Iuso A, Scacco S, Piccoli C, Bellomo F, Petruzzella V, et al. (2006) Dysfunctions
of Cellular Oxidative Metabolism in Patients with Mutations in the NDUFS1
and NDUFS4 Genes of Complex I*. J Biol Chem 281: 10374–10380.
33. Sierra AY, Gratacos E, Carrasco P, Clotet J, Urena J, et al. (2008) CPT1c Is
Localized in Endoplasmic Reticulum of Neurons and Has Carnitine Palmitoyl-
transferase Activity. J Biol Chem 283: 6878–6885.
34. Kurtoglu M, Lampidis TJ (2009) From delocalized lipophilic cations to hypoxia:
Blocking tumor cell mitochondrial function leads to therapeutic gain with
glycolytic inhibitors. Mol Nutr Food Res 53: 68–75.
35. Chandler C, Deady JLW, Reiss JA (1981) Synthesis of some 2,9-Disubstituted-
1,10-phenanthrolines. J Heterocycl Chem 18: 599–601.
36. Freshney RI (2005) Culture of Animal Cells: A Manual of Basic Technique, 5
th
eds Wiley John & Sons, Incorporated. 365 p.
Mitochondria-ER Targeting by Macrocyclic Compounds
PLoS ONE | www.plosone.org 9 November 2011 | Volume 6 | Issue 11 | e27078